71 related articles for article (PubMed ID: 9809986)
1. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid.
Price SA; Tisdale MJ
Cancer Res; 1998 Nov; 58(21):4827-31. PubMed ID: 9809986
[TBL] [Abstract][Full Text] [Related]
2. Modulation of adipocyte G-protein expression in cancer cachexia by a lipid-mobilizing factor (LMF).
Islam-Ali B; Khan S; Price SA; Tisdale MJ
Br J Cancer; 2001 Sep; 85(5):758-63. PubMed ID: 11531264
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of lipid mobilization associated with cancer cachexia: interaction between the polyunsaturated fatty acid, eicosapentaenoic acid, and inhibitory guanine nucleotide-regulatory protein.
Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 1993 Jan; 48(1):105-9. PubMed ID: 8380931
[TBL] [Abstract][Full Text] [Related]
4. Effect of eicosapentaenoic acid (EPA) on expression of a lipid mobilizing factor in adipose tissue in cancer cachexia.
Russell ST; Tisdale MJ
Prostaglandins Leukot Essent Fatty Acids; 2005 Jun; 72(6):409-14. PubMed ID: 15899583
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Hirai K; Hussey HJ; Barber MD; Price SA; Tisdale MJ
Cancer Res; 1998 Jun; 58(11):2359-65. PubMed ID: 9622075
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumour growth in vivo by eicosapentaenoic acid.
Tisdale MJ; Beck SA
Biochem Pharmacol; 1991 Jan; 41(1):103-7. PubMed ID: 1846070
[TBL] [Abstract][Full Text] [Related]
7. Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.
Beck SA; Smith KL; Tisdale MJ
Cancer Res; 1991 Nov; 51(22):6089-93. PubMed ID: 1657378
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid-enriched phospholipids and eicosapentaenoic acid-enriched phospholipids inhibit tumor necrosis factor-alpha-induced lipolysis in 3T3-L1 adipocytes by activating sirtuin 1 pathways.
Yang YH; Hao YM; Liu XF; Gao X; Wang BZ; Takahashi K; Du L
Food Funct; 2021 Jun; 12(11):4783-4796. PubMed ID: 34100500
[TBL] [Abstract][Full Text] [Related]
10. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
12. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids.
Sauer LA; Dauchy RT; Blask DE
Cancer Res; 2000 Sep; 60(18):5289-95. PubMed ID: 11016660
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of adenylyl cyclase activity in brain membrane fractions by arachidonic acid and related unsaturated fatty acids.
Nakamura J; Okamura N; Usuki S; Bannai S
Arch Biochem Biophys; 2001 May; 389(1):68-76. PubMed ID: 11370673
[TBL] [Abstract][Full Text] [Related]
14. In contrast with docosahexaenoic acid, eicosapentaenoic acid and hypolipidaemic derivatives decrease hepatic synthesis and secretion of triacylglycerol by decreased diacylglycerol acyltransferase activity and stimulation of fatty acid oxidation.
Berge RK; Madsen L; Vaagenes H; Tronstad KJ; Göttlicher M; Rustan AC
Biochem J; 1999 Oct; 343 Pt 1(Pt 1):191-7. PubMed ID: 10493929
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid is more effective than docosahexaenoic acid in inhibiting proinflammatory mediator production and transcription from LPS-induced human asthmatic alveolar macrophage cells.
Mickleborough TD; Tecklenburg SL; Montgomery GS; Lindley MR
Clin Nutr; 2009 Feb; 28(1):71-7. PubMed ID: 19054597
[TBL] [Abstract][Full Text] [Related]
16. Eicosapentaenoic acid and docosahexaenoic acid effects on tumour mitochondrial metabolism, acyl CoA metabolism and cell proliferation.
Colquhoun A; Ramos KL; Schumacher RI
Cell Biochem Funct; 2001 Jun; 19(2):97-105. PubMed ID: 11335934
[TBL] [Abstract][Full Text] [Related]
17. Effect of a tumour-produced lipid-mobilizing factor on protein synthesis and degradation.
Islam-Ali BS; Tisdale MJ
Br J Cancer; 2001 Jun; 84(12):1648-55. PubMed ID: 11401319
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II enhances the expression of Gialpha in A10 cells (smooth muscle): relationship with adenylyl cyclase activity.
Palaparti A; Ge C; Anand-Srivastava MB
Arch Biochem Biophys; 1999 May; 365(1):113-22. PubMed ID: 10222045
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid and docosahexaenoic acid modulate mitogen-activated protein kinase activity in endothelium.
Xue H; Wan M; Song D; Li Y; Li J
Vascul Pharmacol; 2006 Jun; 44(6):434-9. PubMed ID: 16616699
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of lipolysis and muscle protein degradation by EPA in cancer cachexia.
Tisdale MJ
Nutrition; 1996 Jan; 12(1 Suppl):S31-3. PubMed ID: 8850217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
